Literature DB >> 3840999

Co-release of neuropeptide Y and catecholamines during physical exercise in man.

J M Lundberg, A Martinsson, A Hemsén, E Theodorsson-Norheim, J Svedenhag, B Ekblom, P Hjemdahl.   

Abstract

Venous plasma levels of neuropeptide Y-like immunoreactivity (with chromatographic properties of synthetic neuropeptide Y) increased in parallel with catecholamines, heart rate and blood pressure during graded physical exercise in man. The plasma levels of neuropeptide Y correlated better with the levels of noradrenaline than adrenaline, suggesting release of a neural origin. Taken together with previous results, this suggests that neuropeptide Y is released together with noradrenaline upon sympathetic activation during physiological conditions in man. Determinations of plasma neuropeptide Y may therefore be valuable in the assessment of sympathetic nerve activity.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3840999     DOI： 10.1016/0006-291x(85)91837-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  33 in total

Review 1.  Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex.

Authors:  C Delarue; V Contesse; S Lenglet; F Sicard; V Perraudin; H Lefebvre; M Kodjo; F Leboulenger; L Yon; N Gallo-Payet; H Vaudry
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Alpha-adrenergic inhibition increases collateral circuit conductance in rats following acute occlusion of the femoral artery.

Authors:  Jessica C Taylor; Zeyi Li; H T Yang; M Harold Laughlin; Ronald L Terjung
Journal:  J Physiol       Date:  2008-01-24       Impact factor: 5.182

3.  Alpha-adrenergic and neuropeptide Y Y1 receptor control of collateral circuit conductance: influence of exercise training.

Authors:  Jessica C Taylor; H T Yang; M Harold Laughlin; Ronald L Terjung
Journal:  J Physiol       Date:  2008-11-03       Impact factor: 5.182

4.  Effect of physical training on reduction of circulating neuropeptide Y levels in elderly humans.

Authors:  V Coiro; A Casti; E Volta; A Melani; P Rubino; G Saccani-Jotti; R Volpi; P Chiodera
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

Review 5.  New aspects of placental endocrinology.

Authors:  F Petraglia; L Calzà; G C Garuti; L Giardino; B M De Ramundo; S Angioni
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

6.  Effects of the neuropeptide YY1 receptor antagonist SR 120107A on sympathetic vascular control in pigs in vivo .

Authors:  R E Malmström; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

7.  Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs.

Authors:  M F Poncet; C Damase-Michel; G Tavernier; M A Tran; M Berlan; J L Montastruc; P Montastruc
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

8.  Localization of neuropeptide Y Y1 receptors in cerebral blood vessels.

Authors:  L Bao; J Kopp; X Zhang; Z Q Xu; L F Zhang; H Wong; J Walsh; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

9.  The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.

Authors:  Duc Quyen Chu; Helen M Cox; Soraia K P Costa; Herbert Herzog; Susan D Brain
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

10.  Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein.

Authors:  Karim Abid; Bertrand Rochat; Paul-Gerhard Lassahn; Reto Stöcklin; Sophie Michalet; Noureddine Brakch; Jean-Francois Aubert; Bilgin Vatansever; Patricia Tella; Ingrid De Meester; Eric Grouzmann
Journal:  J Biol Chem       Date:  2009-07-20       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.